Log In
Print
BCIQ
Print
Print this Print this
 

AZD5069

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionCXC chemokine receptor 2 (CXCR2) antagonist
Molecular Target CXC chemokine receptor 2 (CXCR2) (IL8RB)
Mechanism of ActionCXC chemokine receptor 2 (CXCR2) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today